Fig. 1 · Structure
Documents & Downloads
Ezlopitant
NK-1 Receptor Antagonist
Ezlopitant is a selective non-peptidic antagonist of the neurokinin-1 (NK-1) receptor. It effectively inhibits both acute and delayed emetic responses induced by cisplatin in animal models by targeting NK-1 receptors in the central nervous system. This compound shows potential for research applications in pain management, chemotherapy-induced nausea and vomiting, and the study of irritable bowel syndrome.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 147116-64-1 |
| Applications | NK-1 Receptor Antagonist |
| Formula | C31H38N2O |
| Molecular Weight | 454.65 |
| Synonyms | CJ-11,974 |
| SMILES | COC(C=CC(C(C)C)=C1)=C1CN[C@@H](C2CCN3CC2)[C@@H]3C(C4=CC=CC=C4)C5=CC=CC=C5 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.